Literature DB >> 27908327

Ready for Prime Time? Biomarkers in Sepsis.

Brit Long1, Alex Koyfman2.   

Abstract

Sepsis is a common condition managed in the emergency department. Current diagnosis relies on physiologic criteria and suspicion of a source of infection using history, physical examination, laboratory studies, and imaging studies. The infection triggers a host response with the aim to destroy the pathogen, and this response can be measured. A reliable biomarker for sepsis should assist with earlier diagnosis, improve risk stratification, or improve clinical decision making. Current biomarkers for sepsis include lactate, troponin, and procalcitonin. This article discusses the use of lactate, procalcitonin, troponin, and novel biomarkers for use in sepsis. Published by Elsevier Inc.

Entities:  

Keywords:  Biomarkers; Lactate; Proadrenomedullin; Procalcitonin; Sepsis; Troponin

Mesh:

Substances:

Year:  2017        PMID: 27908327     DOI: 10.1016/j.emc.2016.09.004

Source DB:  PubMed          Journal:  Emerg Med Clin North Am        ISSN: 0733-8627            Impact factor:   2.264


  11 in total

1.  Serum miR-146a and miR-150 as Potential New Biomarkers for Hip Fracture-Induced Acute Lung Injury.

Authors:  Li Gan; Tiansheng Sun; Bei Li; Jing Tian; Jianzheng Zhang; Xiaobin Chen; Jianfeng Zhong; Xiao Yang; Qi Li
Journal:  Mediators Inflamm       Date:  2018-10-28       Impact factor: 4.711

Review 2.  Approach of minimal invasive monitoring and initial treatment of the septic patient in emergency medicine.

Authors:  German Devia Jaramillo; Jenny Castro Canoa; Emiro Valverde Galván
Journal:  Open Access Emerg Med       Date:  2018-11-20

3.  Group IIA secretory phospholipase 2 independently predicts mortality and positive blood culture in emergency department sepsis patients.

Authors:  Utsav Nandi; Alan E Jones; Michael A Puskarich
Journal:  J Am Coll Emerg Physicians Open       Date:  2021-06-18

Review 4.  Metabolomics Profiling As a Diagnostic Tool in Severe Traumatic Brain Injury.

Authors:  Jussi P Posti; Alex M Dickens; Matej Orešič; Tuulia Hyötyläinen; Olli Tenovuo
Journal:  Front Neurol       Date:  2017-08-18       Impact factor: 4.003

5.  Predicting and managing sepsis in burn patients: current perspectives.

Authors:  Omar Nunez Lopez; Janos Cambiaso-Daniel; Ludwik K Branski; William B Norbury; David N Herndon
Journal:  Ther Clin Risk Manag       Date:  2017-08-29       Impact factor: 2.423

6.  Wearable Sensor System for Detection of Lactate in Sweat.

Authors:  Luke J Currano; F Connor Sage; Matthew Hagedon; Leslie Hamilton; Julia Patrone; Konstantinos Gerasopoulos
Journal:  Sci Rep       Date:  2018-10-26       Impact factor: 4.379

7.  Valuable prognostic indicators for severe burn sepsis with inhalation lesion: age, platelet count, and procalcitonin.

Authors:  Yichao Xu; Xinyuan Jin; Xiaonan Shao; Feng Zheng; Hong Zhou
Journal:  Burns Trauma       Date:  2018-10-29

8.  Procalcitonin kinetics after burn injury and burn surgery in septic and non-septic patients - a retrospective observational study.

Authors:  Luís Cabral; Vera Afreixo; Rita Meireles; Miguel Vaz; Margarida Marques; Isabel Tourais; Catarina Chaves; Luís Almeida; José Artur Paiva
Journal:  BMC Anesthesiol       Date:  2018-09-05       Impact factor: 2.217

9.  Use of Procalcitonin to Guide Discontinuation of Antimicrobial Therapy in Patients with Persistent Intra-Abdominal Collections: A Case Series.

Authors:  Gabriel Motoa; Amy Pate; Carlos Franco-Paredes; Daniel B Chastain; Andrés F Henao-Martínez; Leila Hojat
Journal:  Case Rep Infect Dis       Date:  2020-01-09

Review 10.  Lipidomic profile and candidate biomarkers in septic patients.

Authors:  Giovana Colozza Mecatti; Márcia Cristina Fernandes Messias; Patrícia de Oliveira Carvalho
Journal:  Lipids Health Dis       Date:  2020-04-13       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.